BlossomHill Therapeutics is a small molecule drug discovery and development company focused on unmet medical needs in oncology and autoimmune disorders. The company is founded by renowned drug design and development scientist, J. Jean Cui, Ph.D. and biotech veteran, Y. Peter Li, Ph.D., M.B.A. Dr. Cui is the lead inventor of multiple oncology medicines and clinical compounds which include Crizotinib, Lorlatinib, Repotrectinib (TPX-0005), TPX-0022, TPX-0046, and TPX-0131.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 03/04/21 | $71,000,000 | Series A |
Cormorant Asset Management Hercules Bioventures OrbiMed Advisors Vivo Capital | undisclosed |
